Request for Covid-19 Impact Assessment of this Report
The United States Gene Therapy Medicinal Products (GTMP) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gene Therapy Medicinal Products (GTMP) market, reaching US$ million by the year 2028. As for the Europe Gene Therapy Medicinal Products (GTMP) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Gene Therapy Medicinal Products (GTMP) players cover Bluebird Bio, Sangamo, Spark Therapeutics, and Dimension Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy Medicinal Products (GTMP) market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Oral
Injection
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Cancer
Monogenic
Infectious Disease
Cardiovascular Disease
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gene Therapy Medicinal Products (GTMP) Market Size 2017-2028
2.1.2 Gene Therapy Medicinal Products (GTMP) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Gene Therapy Medicinal Products (GTMP) Segment by Type
2.2.1 Oral
2.2.2 Injection
2.3 Gene Therapy Medicinal Products (GTMP) Market Size by Type
2.3.1 Gene Therapy Medicinal Products (GTMP) Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Type (2017-2022)
2.4 Gene Therapy Medicinal Products (GTMP) Segment by Application
2.4.1 Cancer
2.4.2 Monogenic
2.4.3 Infectious Disease
2.4.4 Cardiovascular Disease
2.4.5 Other
2.5 Gene Therapy Medicinal Products (GTMP) Market Size by Application
2.5.1 Gene Therapy Medicinal Products (GTMP) Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Application (2017-2022)
3 Gene Therapy Medicinal Products (GTMP) Market Size by Player
3.1 Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Players
3.1.1 Global Gene Therapy Medicinal Products (GTMP) Revenue by Players (2020-2022)
3.1.2 Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Players (2020-2022)
3.2 Global Gene Therapy Medicinal Products (GTMP) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Gene Therapy Medicinal Products (GTMP) by Regions
4.1 Gene Therapy Medicinal Products (GTMP) Market Size by Regions (2017-2022)
4.2 Americas Gene Therapy Medicinal Products (GTMP) Market Size Growth (2017-2022)
4.3 APAC Gene Therapy Medicinal Products (GTMP) Market Size Growth (2017-2022)
4.4 Europe Gene Therapy Medicinal Products (GTMP) Market Size Growth (2017-2022)
4.5 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size Growth (2017-2022)
5 Americas
5.1 Americas Gene Therapy Medicinal Products (GTMP) Market Size by Country (2017-2022)
5.2 Americas Gene Therapy Medicinal Products (GTMP) Market Size by Type (2017-2022)
5.3 Americas Gene Therapy Medicinal Products (GTMP) Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy Medicinal Products (GTMP) Market Size by Region (2017-2022)
6.2 APAC Gene Therapy Medicinal Products (GTMP) Market Size by Type (2017-2022)
6.3 APAC Gene Therapy Medicinal Products (GTMP) Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Gene Therapy Medicinal Products (GTMP) by Country (2017-2022)
7.2 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Type (2017-2022)
7.3 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gene Therapy Medicinal Products (GTMP) by Region (2017-2022)
8.2 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Type (2017-2022)
8.3 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Gene Therapy Medicinal Products (GTMP) Market Forecast
10.1 Global Gene Therapy Medicinal Products (GTMP) Forecast by Regions (2023-2028)
10.1.1 Global Gene Therapy Medicinal Products (GTMP) Forecast by Regions (2023-2028)
10.1.2 Americas Gene Therapy Medicinal Products (GTMP) Forecast
10.1.3 APAC Gene Therapy Medicinal Products (GTMP) Forecast
10.1.4 Europe Gene Therapy Medicinal Products (GTMP) Forecast
10.1.5 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Forecast
10.2 Americas Gene Therapy Medicinal Products (GTMP) Forecast by Country (2023-2028)
10.2.1 United States Gene Therapy Medicinal Products (GTMP) Market Forecast
10.2.2 Canada Gene Therapy Medicinal Products (GTMP) Market Forecast
10.2.3 Mexico Gene Therapy Medicinal Products (GTMP) Market Forecast
10.2.4 Brazil Gene Therapy Medicinal Products (GTMP) Market Forecast
10.3 APAC Gene Therapy Medicinal Products (GTMP) Forecast by Region (2023-2028)
10.3.1 China Gene Therapy Medicinal Products (GTMP) Market Forecast
10.3.2 Japan Gene Therapy Medicinal Products (GTMP) Market Forecast
10.3.3 Korea Gene Therapy Medicinal Products (GTMP) Market Forecast
10.3.4 Southeast Asia Gene Therapy Medicinal Products (GTMP) Market Forecast
10.3.5 India Gene Therapy Medicinal Products (GTMP) Market Forecast
10.3.6 Australia Gene Therapy Medicinal Products (GTMP) Market Forecast
10.4 Europe Gene Therapy Medicinal Products (GTMP) Forecast by Country (2023-2028)
10.4.1 Germany Gene Therapy Medicinal Products (GTMP) Market Forecast
10.4.2 France Gene Therapy Medicinal Products (GTMP) Market Forecast
10.4.3 UK Gene Therapy Medicinal Products (GTMP) Market Forecast
10.4.4 Italy Gene Therapy Medicinal Products (GTMP) Market Forecast
10.4.5 Russia Gene Therapy Medicinal Products (GTMP) Market Forecast
10.5 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Forecast by Region (2023-2028)
10.5.1 Egypt Gene Therapy Medicinal Products (GTMP) Market Forecast
10.5.2 South Africa Gene Therapy Medicinal Products (GTMP) Market Forecast
10.5.3 Israel Gene Therapy Medicinal Products (GTMP) Market Forecast
10.5.4 Turkey Gene Therapy Medicinal Products (GTMP) Market Forecast
10.5.5 GCC Countries Gene Therapy Medicinal Products (GTMP) Market Forecast
10.6 Global Gene Therapy Medicinal Products (GTMP) Forecast by Type (2023-2028)
10.7 Global Gene Therapy Medicinal Products (GTMP) Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Bluebird Bio
11.1.1 Bluebird Bio Company Information
11.1.2 Bluebird Bio Gene Therapy Medicinal Products (GTMP) Product Offered
11.1.3 Bluebird Bio Gene Therapy Medicinal Products (GTMP) Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bluebird Bio Main Business Overview
11.1.5 Bluebird Bio Latest Developments
11.2 Sangamo
11.2.1 Sangamo Company Information
11.2.2 Sangamo Gene Therapy Medicinal Products (GTMP) Product Offered
11.2.3 Sangamo Gene Therapy Medicinal Products (GTMP) Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Sangamo Main Business Overview
11.2.5 Sangamo Latest Developments
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Information
11.3.2 Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Product Offered
11.3.3 Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Spark Therapeutics Main Business Overview
11.3.5 Spark Therapeutics Latest Developments
11.4 Dimension Therapeutics
11.4.1 Dimension Therapeutics Company Information
11.4.2 Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Product Offered
11.4.3 Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Dimension Therapeutics Main Business Overview
11.4.5 Dimension Therapeutics Latest Developments
11.5 Avalanche Bio
11.5.1 Avalanche Bio Company Information
11.5.2 Avalanche Bio Gene Therapy Medicinal Products (GTMP) Product Offered
11.5.3 Avalanche Bio Gene Therapy Medicinal Products (GTMP) Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Avalanche Bio Main Business Overview
11.5.5 Avalanche Bio Latest Developments
11.6 Celladon
11.6.1 Celladon Company Information
11.6.2 Celladon Gene Therapy Medicinal Products (GTMP) Product Offered
11.6.3 Celladon Gene Therapy Medicinal Products (GTMP) Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Celladon Main Business Overview
11.6.5 Celladon Latest Developments
11.7 Vical Inc.
11.7.1 Vical Inc. Company Information
11.7.2 Vical Inc. Gene Therapy Medicinal Products (GTMP) Product Offered
11.7.3 Vical Inc. Gene Therapy Medicinal Products (GTMP) Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Vical Inc. Main Business Overview
11.7.5 Vical Inc. Latest Developments
11.8 Advantagene
11.8.1 Advantagene Company Information
11.8.2 Advantagene Gene Therapy Medicinal Products (GTMP) Product Offered
11.8.3 Advantagene Gene Therapy Medicinal Products (GTMP) Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Advantagene Main Business Overview
11.8.5 Advantagene Latest Developments
12 Research Findings and Conclusion
Table 1. Gene Therapy Medicinal Products (GTMP) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injection
Table 4. Gene Therapy Medicinal Products (GTMP) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Gene Therapy Medicinal Products (GTMP) Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Type (2017-2022)
Table 7. Gene Therapy Medicinal Products (GTMP) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Gene Therapy Medicinal Products (GTMP) Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Application (2017-2022)
Table 10. Global Gene Therapy Medicinal Products (GTMP) Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Player (2020-2022)
Table 12. Gene Therapy Medicinal Products (GTMP) Key Players Head office and Products Offered
Table 13. Gene Therapy Medicinal Products (GTMP) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene Therapy Medicinal Products (GTMP) Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Regions (2017-2022)
Table 18. Americas Gene Therapy Medicinal Products (GTMP) Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Country (2017-2022)
Table 20. Americas Gene Therapy Medicinal Products (GTMP) Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Type (2017-2022)
Table 22. Americas Gene Therapy Medicinal Products (GTMP) Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Application (2017-2022)
Table 24. APAC Gene Therapy Medicinal Products (GTMP) Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Region (2017-2022)
Table 26. APAC Gene Therapy Medicinal Products (GTMP) Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Type (2017-2022)
Table 28. APAC Gene Therapy Medicinal Products (GTMP) Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Application (2017-2022)
Table 30. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Country (2017-2022)
Table 32. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Type (2017-2022)
Table 34. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Gene Therapy Medicinal Products (GTMP)
Table 43. Key Market Challenges & Risks of Gene Therapy Medicinal Products (GTMP)
Table 44. Key Industry Trends of Gene Therapy Medicinal Products (GTMP)
Table 45. Global Gene Therapy Medicinal Products (GTMP) Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Gene Therapy Medicinal Products (GTMP) Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Gene Therapy Medicinal Products (GTMP) Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Gene Therapy Medicinal Products (GTMP) Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Gene Therapy Medicinal Products (GTMP) Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Gene Therapy Medicinal Products (GTMP) Market Size Market Share Forecast by Application (2023-2028)
Table 51. Bluebird Bio Details, Company Type, Gene Therapy Medicinal Products (GTMP) Area Served and Its Competitors
Table 52. Bluebird Bio Gene Therapy Medicinal Products (GTMP) Product Offered
Table 53. Bluebird Bio Gene Therapy Medicinal Products (GTMP) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Bluebird Bio Main Business
Table 55. Bluebird Bio Latest Developments
Table 56. Sangamo Details, Company Type, Gene Therapy Medicinal Products (GTMP) Area Served and Its Competitors
Table 57. Sangamo Gene Therapy Medicinal Products (GTMP) Product Offered
Table 58. Sangamo Main Business
Table 59. Sangamo Gene Therapy Medicinal Products (GTMP) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Sangamo Latest Developments
Table 61. Spark Therapeutics Details, Company Type, Gene Therapy Medicinal Products (GTMP) Area Served and Its Competitors
Table 62. Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Product Offered
Table 63. Spark Therapeutics Main Business
Table 64. Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Spark Therapeutics Latest Developments
Table 66. Dimension Therapeutics Details, Company Type, Gene Therapy Medicinal Products (GTMP) Area Served and Its Competitors
Table 67. Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Product Offered
Table 68. Dimension Therapeutics Main Business
Table 69. Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Dimension Therapeutics Latest Developments
Table 71. Avalanche Bio Details, Company Type, Gene Therapy Medicinal Products (GTMP) Area Served and Its Competitors
Table 72. Avalanche Bio Gene Therapy Medicinal Products (GTMP) Product Offered
Table 73. Avalanche Bio Main Business
Table 74. Avalanche Bio Gene Therapy Medicinal Products (GTMP) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Avalanche Bio Latest Developments
Table 76. Celladon Details, Company Type, Gene Therapy Medicinal Products (GTMP) Area Served and Its Competitors
Table 77. Celladon Gene Therapy Medicinal Products (GTMP) Product Offered
Table 78. Celladon Main Business
Table 79. Celladon Gene Therapy Medicinal Products (GTMP) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Celladon Latest Developments
Table 81. Vical Inc. Details, Company Type, Gene Therapy Medicinal Products (GTMP) Area Served and Its Competitors
Table 82. Vical Inc. Gene Therapy Medicinal Products (GTMP) Product Offered
Table 83. Vical Inc. Main Business
Table 84. Vical Inc. Gene Therapy Medicinal Products (GTMP) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Vical Inc. Latest Developments
Table 86. Advantagene Details, Company Type, Gene Therapy Medicinal Products (GTMP) Area Served and Its Competitors
Table 87. Advantagene Gene Therapy Medicinal Products (GTMP) Product Offered
Table 88. Advantagene Main Business
Table 89. Advantagene Gene Therapy Medicinal Products (GTMP) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Advantagene Latest Developments
List of Figures
Figure 1. Gene Therapy Medicinal Products (GTMP) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Type in 2021
Figure 7. Gene Therapy Medicinal Products (GTMP) in Cancer
Figure 8. Global Gene Therapy Medicinal Products (GTMP) Market: Cancer (2017-2022) & ($ Millions)
Figure 9. Gene Therapy Medicinal Products (GTMP) in Monogenic
Figure 10. Global Gene Therapy Medicinal Products (GTMP) Market: Monogenic (2017-2022) & ($ Millions)
Figure 11. Gene Therapy Medicinal Products (GTMP) in Infectious Disease
Figure 12. Global Gene Therapy Medicinal Products (GTMP) Market: Infectious Disease (2017-2022) & ($ Millions)
Figure 13. Gene Therapy Medicinal Products (GTMP) in Cardiovascular Disease
Figure 14. Global Gene Therapy Medicinal Products (GTMP) Market: Cardiovascular Disease (2017-2022) & ($ Millions)
Figure 15. Gene Therapy Medicinal Products (GTMP) in Other
Figure 16. Global Gene Therapy Medicinal Products (GTMP) Market: Other (2017-2022) & ($ Millions)
Figure 17. Global Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Application in 2021
Figure 18. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Player in 2021
Figure 19. Global Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Gene Therapy Medicinal Products (GTMP) Market Size 2017-2022 ($ Millions)
Figure 21. APAC Gene Therapy Medicinal Products (GTMP) Market Size 2017-2022 ($ Millions)
Figure 22. Europe Gene Therapy Medicinal Products (GTMP) Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size 2017-2022 ($ Millions)
Figure 24. Americas Gene Therapy Medicinal Products (GTMP) Value Market Share by Country in 2021
Figure 25. Americas Gene Therapy Medicinal Products (GTMP) Consumption Market Share by Type in 2021
Figure 26. Americas Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Application in 2021
Figure 27. United States Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Region in 2021
Figure 32. APAC Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Application in 2021
Figure 33. China Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Country in 2021
Figure 40. Europe Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Type in 2021
Figure 41. Europe Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Application in 2021
Figure 42. Germany Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size Market Share by Application in 2021
Figure 50. Egypt Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Gene Therapy Medicinal Products (GTMP) Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 56. APAC Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 57. Europe Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 59. United States Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 60. Canada Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 63. China Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 64. Japan Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 65. Korea Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 67. India Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 68. Australia Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 69. Germany Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 70. France Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 71. UK Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 72. Italy Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 73. Russia Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 74. Spain Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 77. Israel Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Gene Therapy Medicinal Products (GTMP) Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...